NACDS MODULE 3 EXAM WITH CORRECT
ACTUAL QUESTIONS AND CORRECTLY
WELL DEFINED ANSWERS LATEST 2025
ALREADY GRADED A+
Knowledge and training of the staff running the test
The FDA assesses the complexity of the POCT when determining if the test
qualifies for a CLIA-waiver. Which of the following are evaluated in this
determination?
The sample being analyzed using the POCT
This lesson discussed the number of CLIA-waived analytes approved by the FDA.
What is an analyte?
The time personnel devote to the test
The expense of any consumables used for the test, but not included with the test
The selection decision on a CLIA-waived test for a pharmacy-based patient care
service includes cost. Which of the following costs should be considered
Competitive assay
Which of the following tests has the potential to test for multiple pathogens at
the same time?
ACTUAL QUESTIONS AND CORRECTLY
WELL DEFINED ANSWERS LATEST 2025
ALREADY GRADED A+
Knowledge and training of the staff running the test
The FDA assesses the complexity of the POCT when determining if the test
qualifies for a CLIA-waiver. Which of the following are evaluated in this
determination?
The sample being analyzed using the POCT
This lesson discussed the number of CLIA-waived analytes approved by the FDA.
What is an analyte?
The time personnel devote to the test
The expense of any consumables used for the test, but not included with the test
The selection decision on a CLIA-waived test for a pharmacy-based patient care
service includes cost. Which of the following costs should be considered
Competitive assay
Which of the following tests has the potential to test for multiple pathogens at
the same time?
